The anti-inflammatory response to the systemic inflammatory response syndrome manifests across a range of cellular actions and functions, involving both the innate and adaptive arms of the immune system. 4 Defects have been noted in neutrophils, 5 -8 monocytes, 9 T lymphocytes, 10 and B lymphocytes and also splenic dendritic cells. 11 12 The recent identification of elevated levels of regulatory helper-T cells (Tregs) in sepsis 13 is in keeping with the supposition that much of the immunosuppression arises from the overactivation of counter-regulatory mechanisms. In human and experimental sepsis, Tregs impair the proliferative response of lymphocytes. 14 The demands of organ support require the disruption of physical and physiological barriers through the placement of devices such as endo-tracheal tubes. It is thought that the combination of immune vulnerability and such routes of microbial colonization are responsible for the high rates of nosocomial infection seen in critically ill patients. 15 These secondary infections typically occur in 25-35% of those admitted to intensive care units (ICUs), 15 a rate that approaches that seen in neutropaenia. 16 These infections are associated with increased length of stay, 17 morbidity 18 and mortality, 19 and therefore are of considerable concern to patients and clinicians. Although it seems plausible that the immune defects found in critical illness are associated with the acquisition of nosocomial infection, there is little published evidence for this, and what data there are concentrate on single types of immune cell. Furthermore, the temporal relationship between immune dysfunction and nosocomial infection is not always clear, 6 limiting any inferences regarding causality. This study aimed to characterize the temporal patterns of three measures of immune dysfunction, sampling both the innate and adaptive arms of the immune system, and to derive potential new biomarkers of susceptibility to nosocomial infection. The cell types and measures of dysfunction chosen were the level of Tregs as a percentage of all CD4+ lymphocytes, 14 monocyte deactivation assayed by monocyte HLA-DR expression 9 and C5a-mediated neutrophil dysfunction assayed by surface CD88 expression. 6 8 Methods
Reagents
Fluorescein isothiocyanate (FITC)-conjugated murine antihuman CD4, allophycocyanin-conjugated murine anti-human CD25, and phycoerythrin (PE)-conjugated murine anti-human FOXP3 antibodies were obtained from eBioscience (San Diego, CA, USA). Red cell lysis buffer, fixation/permeabilization solution, and flow staining buffer were obtained from eBioscience. Alexa Fluor TM 647-conjugated murine anti-human CD88 antibodies were obtained from AbD Serotec (Abingdon, UK), and QuantiBRITE monocyte HLA-DR assay was obtained from Becton Dickson Biosciences (Oxford, UK). Tri-colour-conjugated murine anti-human CD16 and CD62L, FITC-conjugated murine anti-human CD11b and CD14, and PE-conjugated murine anti-human CD3 and CD64 were obtained from Invitrogen (Paisley, UK).
Volunteers, patients, and setting
Healthy volunteers were recruited from University of Edinburgh staff, to act as a reference group for the cellular markers examined.
The clinical study took place in an 18-bed teaching hospital medical-surgical ICU.
Critically ill patients, defined as those admitted to ICU and requiring support of one or more organ systems (invasive ventilation; requirement for vasopressors, inotropes, or both haemofiltration) and predicted to require such support for 48 h or more, were screened for recruitment. Exclusion criteria were: age ,16; pregnancy; known human immunodeficiency virus infection; known in-born errors of neutrophil metabolism; haematological malignancy; use of immunosuppressive drugs other than corticosteroids; and those thought unlikely to survive for .24 h. Patients were also excluded if they were involved in another study that involved blood sampling, or if they had suspected novel (A/H1N1) influenza. Informed consent was obtained directly from patients where possible, otherwise informed consent was obtained from the next of kin. Clinical data were collected regarding potential risk factors for nosocomial infection, 15 these data included 'shock', defined by requirement for norepinephrine, epinephrine, dobutamine infusion, or both. Ethylenediaminetetraacetic acid anti-coagulated blood was collected at study enrolment (within 48 h of ICU admission), then at study Day 2, Days 3-4, and Days 6-10 unless a study endpoint was achieved. Study endpoints were ICU-acquired infection (see Supplementary material for definition); death without ICU-acquired infection; or discharge from ICU without ICU-acquired infection. Details of flow cytometric protocols and analysis for determination of immune dysfunction are included in the Supplementary material.
Infections
Diagnostic criteria were pre-defined for the major ICUacquired infections, namely ventilator-associated pneumonia (VAP), blood stream infection (BSI), vascular catheter-related infection (CRI), urinary tract infection (UTI) and surgical site/ soft tissue infections, based on those from the HELICS programme 20 (see Supplementary material for details). Data on infections were recorded by the study nurses (J.A. and C.M.), who were blinded to the immune phenotype. Day of infection was defined as the day on which positive microbial culture was obtained from the patient.
Where infection was strongly clinically suspected but did not fulfil HELICS criteria (for instance when cultures were taken while on antibiotics, cultures, or both were negative/ equivocal), an expert panel (I.F.L., A.W.H., D.G.S., T.S.W., and A.J.S.), blinded to the immune phenotype, reviewed patients' data and the presence or absence of infection was adjudicated. In the absence of positive culture the day of infection was defined as the day of clinical deterioration. The adjudication outcome could be 'confirmed', 'probable', or 'unlikely' infection. Details of diagnostic criteria and expert panel adjudication procedures are set out in the Supplementary material. 
Ethical approval
Written informed consent was obtained from the patient, or where incapacitated from their nearest relative. The study was approved by the Scotland A Research Ethics committee (study number 09/MRE00/19). Healthy volunteers provided written informed consent, and their involvement was approved by Lothian Research Ethics committee (study number 08/ S1103/38). Data relating to C5a-mediated dysfunction in the first 60 patients described here have been published elsewhere in a paper delineating the mechanisms of C5a-dependent impairment of neutrophil phagocytosis and its clinical relevance. 8 
Results

Recruitment
Ninety-six patients were recruited. Blood samples were missing for one patient and so 95 entered the final analysis. Forty-two (44%) patients were admitted with sepsis, nine of whom had acquired their infection in hospital before ICU admission. Details of sites and organisms involved are given in the Supplemental material.
Infections
Thirty-three patients (35%) developed nosocomial infection whilst in ICU (26 confirmed infections and seven probable). Details of the sites of infections are given in Table 1 , infecting organisms are given in Table 2 . The median length of stay before developing infection was 6 days (IQR 5-7 days). In total 20 patients underwent adjudication panel review, five were ruled 'confirmed', seven 'probable' and eight 'unlikely'. Further details of adjudications can be found in the Supplementary material. Among the patients admitted with sepsis, who subsequently developed ICU-acquired infection, the organisms differed in every patient and in all but one situation the site of the new infection was different (the exception being a patient admitted with bronchoalveolar lavage polymerase chain reaction-positive Varicella pneumonitis who subsequently developed Gram-negative bacterial VAP).
Twenty-two (23%) patients died during their ICU admission, 11 (50%) were judged to have died of a septic insult, including five with an admission diagnosis of sepsis and six who developed secondary sepsis from an ICU-acquired infection.
Details of total and differential white cell counts at each time point are given in the Supplementary material, Figure S2 .
Regulatory T-cells
The percentage of Tregs at the various time points after study entry, compared with healthy donors Treg levels, were higher than those seen in healthy donors (P¼0.018 by ANOVA, data not shown). When divided into patients developing nosocomial infection in the ICU and those not, Tregs were significantly higher amongst patients developing infection (P¼0.012) (Fig. 1A) . 
Monocyte deactivation
The expression of monocyte surface HLA-DR was significantly suppressed relative to healthy volunteers (P,0.0001 by ANOVA data not shown). Patients developing nosocomial infections had significantly lower levels of monocyte HLA-DR than those who did not (P¼0.018) (Fig. 1B) .
Complement mediated neutrophil dysfunction
Significantly depressed levels of neutrophil CD88 were found in patients, relative to healthy donors (P,0.001 by ANOVA, data not shown). Again patients who subsequently developed nosocomial infection displayed lower levels of CD88, implying greater levels of C5a exposure (P¼0.001) (Fig. 1C) . In keeping with our previous work showing the specific association between CD88 expression and neutrophil dysfunction, 6 8 no association was found between nosocomial infection and other markers of neutrophil activation (CD11b, CD64 and L-selectin, data not shown), suggesting that the effect seen is not reflective of generic activation. This is in contrast to other work suggesting a diagnostic role for CD11b and CD64 for infection, 21 however we examined the ability of markers to predict future infection rather than diagnose it after it had occurred.
Examining the cut-off for dysfunction by relationship to infection
At the planned interim analysis, 8 the optimal cut-points were examined using receiver-operator characteristic curves and Youdens index; 22 this revealed an optimal of 9.8% for Tregs, 10 000 molecules per cell for HLA-DR and a geometric mean fluorescence of 246 for CD88. Thirty-seven patients had Treg levels .9.8% before achieving a study endpoint (i.e. ICU-acquired infection, death without infection, or discharge without infection), the majority of whom (26, 70%) had normal levels on study admission. The remaining 58 patients had levels ,9.8%, although in 8 (14%) of them levels had started .9.8% and decreased before study endpoint. As noted above, in patients acquiring infection in ICU, data were censored for 2 days before infection for purposes of classifying Treg status. This changeability in Treg status led us to analyse this as a time-dependent variable in the Cox hazard analysis (see below). Of note, many patients showed evidence of increased CD25 positive lymphocytes, a known marker of lymphocyte activation, 23 reinforcing the need for FOXP3 staining in addition to cell surface markers of regulatory status. 24 Sixty-two patients had monocyte dysfunction while 69 had neutrophil dysfunction. In contrast to the Tregs, patients were far less likely to change from 'dysfunction' to 'no dysfunction' (or vice versa) with respect to monocyte HLA-DR and neutrophil CD88 expression. Seventy-five per cent of patients remained in the same monocyte group as their admission sample, whilst 13% progressed from 'no dysfunction' to 'dysfunction' and 14% went in the opposite direction. Of the minority who changed groups, all but two were in their eventual group by Day 3 post-admission. Regarding neutrophil groups 84% of patients remained in the same group as their admission sample, while 13% progressed from 'no dysfunction' to 'dysfunction' and 3% went in the opposite direction. Of the minority who changed groups, all but three were in their eventual group by Day 3 post-admission. 
Effect of dysfunction on acquisition of infection
Evaluation of the impact of other clinical variables on acquisition of infection
As an exploratory analysis data concerning patient characteristic and clinical factors previously associated with nosocomial infection 15 were entered into a Cox hazards model, in a conditional stepwise approach using a threshold of P≤0.05 (Table 3) . Elevated Tregs were treated as a time-dependent co-variate as this measure showed considerable variability over time. In this model, both Tregs and neutrophil dysfunction retained their significant association (Table 4) , however monocyte deactivation became non-significant (P¼0.29) and was excluded from the final model. The only clinical predictor found to be significant was blood transfusion, which was associated with a lower risk of nosocomial infection. The overall model and hazard ratio estimates for the predictor variables are given in Table 4 . An alternative method of variable selection for the Cox model, using univariate regression resulted in Tregs and neutrophil dysfunction remaining significant at P¼0.05 but again monocyte deactivation lost significance (Supplementary material, Tables S3 and S4) .
Finally, the effect of cumulative occurrence of immune dysfunction was analysed. Patients were analysed by whether they had 0, 1, 2, or 3 dysfunctions (Table 5) .
This demonstrated an incremental risk of nosocomial infection with accumulating immune dysfunctions, ranging from none in those patients without immune dysfunctions to 75% of those who had all three (P¼0.0004 by x 2 test for trend). Cumulative immune dysfunction did not predict all-cause mortality (P¼0.25 by x 2 test for trend), but was highly significant when looking at deaths from sepsis (P¼0.0072 x 2 test for trend).
Effect of infection on dysfunction
To examine whether the development of ICU-acquired infection altered the measures of dysfunction, samples from time Table 3 Patient characteristic and clinical factors among those with and without nosocomial infection. Right hand column indicates P-value for hazard ratios determined during stepwise conditional evaluation, variables marked *entered the final model (see Table 4 ) points before and after ICU-acquired infection were examined ( Fig. 2A -C) and demonstrated no significant change across the time intervals examined. Analysis of the measures of dysfunction in the first samples obtained from patients with and without infection on admission revealed no significant difference between these two groups (% Tregs P¼0.41, HLA-DR P¼0.49, CD88 P¼0.73, by t-test on log-transformed data).
Discussion
This study demonstrates the temporal course of three measures of immune dysfunction amongst critically ill patients, illustrating that immune dysfunction is not an 'all or nothing' response and can affect different cell types at different times. Although the magnitude of immune dysfunction appears to worsen as the critical illness progresses, in many cases patients demonstrate dysfunction early on (i.e. within 48 h of ICU admission). Interestingly, this study does not support the recent suggestion that immune dysfunction is restricted to patients with sepsis, 12 as we found evidence of dysfunction among patients with both sterile and infective causes of critical illness. This study demonstrates, for the first time, an association between elevated Tregs and the acquisition of nosocomial infection. The association with infection is also extended to diminished neutrophil CD88 expression, and both compare well to the more established marker, reduced monocyte HLA-DR. 9 This study involved the assessment of several distinct mechanisms of immune dysfunction, and allowed for dynamic changes in immune cell function rather than relying on a single time point. Immunophenotyping in critical illness is a relatively new field, and determining what constitutes 'immune dysfunction' and how this could be determined by quantifying cell surface markers remains uncertain. This study, while exploratory in nature, has derived two potential new markers for susceptibility to nosocomial infection alongside a more established marker.
It is interesting that the cut-offs determined by examining patients with and without nosocomial infection were close to those suggested by more mechanistic work. A cut-off of 10% of CD4 cells was suggested as an indicator of inappropriately elevated Tregs in a recent study, 14 very close to our value of 9.8%. Similarly, the cut-off for CD88 of 246 arbitrary fluorescence units is close to the value of 250 which in our hands corresponded to 50% of neutrophils capable of efficient phagocytosis of zymosan in patients. 8 The cut-off described here is also close to the value we observed when healthy volunteer neutrophils were exposed to 10 nM C5a 8 which is well within the concentration range seen in severe sepsis. 25 Our cut-off for HLA-DR was higher than that described in previous studies 9 although the previous measure was looking at risk of death rather than the development of nosocomial infection. The infections had to meet rigorous, reproducible criteria and any patients not meeting these criteria underwent review by experts blinded to the immune cell data. UTI can be difficult to discern in critically ill patients, given the risk of bladder colonization with catheterization. 26 However, those patients acquiring UTI had no clinical or microbiological evidence of infection from other sites and all exceeded the rigorous microbiological criteria set before the study (i.e. all UTIs were single organisms grown at high concentrations of .10 6 CFU ml 21 ). Encouragingly, excluding UTIs or infections only judged 'probable' did not significantly reduce the predictive ability of our immune markers. These findings will, however, require further confirmation in an independent validation data set. As with any observational study, we cannot be certain that the observed associations are causative; however, we took steps to minimize the risk of picking up epiphenomenal changes associated with infection. Indeed, analysis of the measures before and after the acquisition of infection did not support a simple, epiphenomenal relationship. Furthermore, it is biologically plausible that immune dysfunction is causally linked to the acquisition of nosocomial infection. Although we cannot rule out the effect of residual confounding from unmeasured variables, we have accounted for many of the risk factors previously mooted for nosocomial infection. 15 Several studies have demonstrated elevated levels of Tregs in patients with sepsis, 13 14 and recent animal and in vitro work has shown Tregs mediating impaired T-cell proliferative responses in this disease. 14 The current study extends the findings of elevated Tregs to critically ill patients without sepsis, suggesting that their elevation is the part of a stereotyped response to systemic inflammation rather than a specific response to severe infection. Although the association between elevated Tregs and adverse outcomes is consistent with some previous work, 14 this finding is by no means universal with other studies showing no effect, 27 or even protective effects in animal models. 28 It is also interesting to note the generally increased expression of CD25 noted on CD4 cells from critically ill patients, reflecting the nature of CD25 as a marker of lymphocyte activation 23 and emphasizing the need for additional measures such as FOXP3 for identifying Tregs in this patient population. The field of regulatory T-cell identification is developing rapidly, and additional measures beyond those used in this study may further improve the predictive ability and add new information regarding expression of subsets of regulatory T-cells in critical illness. 29 Indeed the use of CD127 negativity 14 as a marker would eliminate a step of the current process and produce a more rapidly available result; however, these developments would require validation in a further study. Although the finding of monocyte deactivation, and low HLA-DR expression, predicting nosocomial infection is not a new one 30 31 the finding is not universally consistent. 32 The role of excessive complement activation in the pathogenesis of sepsis and non-septic critical illness is increasingly recognized. 33 34 Animal models of sepsis and trauma, and patient studies, have demonstrated C5a-mediated neutrophil dysfunction. To our knowledge, this is the first study to examine several different cellular markers of immune dysfunction simultaneously at multiple time points, and to demonstrate a cumulative effect when it comes to predicting nosocomial infection. It remains a distinct possibility that the effects are not simply additive, but may indeed be synergistic. There is evidence of neutrophil subsets suppressing lymphocyte functions 36 and regulatory T-cells inhibiting neutrophil functions. 37 The current study was not designed to answer such questions; however, the investigation of potential interactions is the subject of ongoing studies. It is interesting to speculate why our study did not show significant effects of many of the patient characteristic and clinical factors that have been previously linked to nosocomial infection. 15 It is important to note that although there are a variety of acknowledged risk factors-including severity of illness, intubation, total parenteral nutrition, and tracheostomy 38 -44 -there is relatively low concordance between studies, which often yielded different combinations of factors. 38 42 -44 Furthermore, many studies do not adequately account for the relationship between interventions such as tracheostomy, or total parenteral nutrition and length of stay (i.e. duration of risk exposure), in that the longer a patient remains in ICU the more likely they are to receive one of these interventions, 41 43 with the added confounder that those acquiring nosocomial infection tend to stay in ICU longer. 42 Many epidemiological studies of infection in ICU include all-comers, whereas in this study, we deliberately recruited a group who were thought to be at high risk. All our patients had some form of invasive device in place, be it a tracheal tube, central venous catheter or haemofiltration line, to facilitate the organ support that was an entry criterion. With a median APACHE II of 22 (IQR 18-28), these patients were a sicker subset of all ITU patients admitted to our unit. The apparent 'protective' effect of blood transfusion was an unexpected finding, as previous studies have suggested it as a risk factor for infection. 43 This could be a genuine effect resulting from hetrologous blood's immunostimulatory effects, 45 or it may relate to failure to correct for unmeasured confounders.
Conclusions
This study has added new knowledge regarding the timing and magnitude of immune dysfunction occurring in critically ill adults, and related these findings to an important clinical outcome, namely the development of nosocomial infection. We have shown that these effects are not restricted to patients with sepsis but occur in those with sterile insults as well. We have also demonstrated the utility of blood cell-based markers of immune dysfunction and thus set the scene for future validation and intervention trials. 
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